Business

Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street.

February 3, 2026 0 views 1 min read
Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street.
Pfizer also releases positive top-line results from a trial for its injectable GLP-1 receptor agonist in adults with obesity.